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Viral control of programmed cell death relies in part on the expression of viral analogs of the
B-cell lymphoma 2 (Bcl2) protein known as viral Bcl2s (vBcl2s). vBcl2s control apoptosis by
interacting with host pro- and anti-apoptotic members of the Bcl2 family. Here, we show that
the carboxyl-terminal hydrophobic region of herpesviral and poxviral vBcl2s can operate as
transmembrane domains (TMDs) and participate in their homo-oligomerization. Additionally,
we show that the viral TMDs mediate interactions with cellular pro- and anti-apoptotic Bcl2
TMDs within the membrane. Furthermore, these intra-membrane interactions among viral
and cellular proteins are necessary to control cell death upon an apoptotic stimulus.
Therefore, their inhibition represents a new potential therapy against viral infections, which
are characterized by short- and long-term deregulation of programmed cell death.
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Programmed cell death is indispensable in multicellularorganisms, contributing to the balance among cell death,proliferation, and differentiation that is crucial for tissue
development and homeostasis1. Furthermore, protection from
and defense against many disorders, including cancer, auto-
immunity, and neurodegeneration, relies on apoptosis and
autophagy2,3. Pathogen-related diseases are no exception, and
efficient control and clearance of infections often require efficient
programmed cell death4,5. Eliminating infected cells through a
controlled death process blocks propagation of the infection and
produces danger signals to stimulate an appropriate immune
response6.
Because of its relevance for cell fate, programmed cell death
is tightly regulated. One of the primary modulators of apoptosis
is the protein family known as B-cell lymphoma 2 (Bcl2)7. The
Bcl2 family (consisting of ~20 proteins) incorporates pro-
survival (e.g., Bcl2 and BclxL)8, pro-apoptotic (e.g., Bax and
Bak9), and BH3-only apoptosis activators (e.g., Bid and Bmf)10.
Proteins are assigned to each subset based on their role in
apoptosis (pro- vs anti-apoptotic), as well as on their sequence
similarity to Bcl2. Most pro- and anti-apoptotic proteins share
all four main Bcl2 sequence homology domains (BH1–4). In
contrast, BH3-only members have only the BH3 domain, as
their name implies. In addition, many Bcl2 family proteins,
including some BH3-only members11, have a transmembrane
domain (TMD) in the carboxyl-terminal (Ct) end that effec-
tively allows for insertion of the protein into the target lipid
bilayer12.
Cellular Bcl2 (cBcl2) proteins can physically interact with each
other, forming homo- and hetero-oligomers9,10,13–16. These
protein–protein interactions (PPIs) constitute an important reg-
ulatory mechanism of programmed cell death. In healthy cells,
anti-apoptotic Bcl2s inhibit the activation of pro-apoptotic pro-
teins, either through direct interaction or sequestering BH3-only
activators7. Upon an apoptotic stimulus, BH3-only and pro-
apoptotic proteins are discharged, promoting mitochondrial
membrane permeabilization and the release of cytochrome c into
the cytosol which, in turn, will activate the apoptosome. Inter-
actions among Bcl2 family members have been thought to occur
only through soluble domains, especially BH domains. However,
recent findings suggested that Bax TMD interacts with pro-
survival Bcl2 proteins17, expanding the range of interactions
involved in the control of programmed cell death.
Viruses have developed multiple strategies to modulate cell
death, including masking of internal cellular sensors, caspase
regulation, signaling cascade modulation, and mimicking of Bcl2
regulators18,19. Functional homologs of cBcl2, known as viral
Bcl2s (vBcl2s; singular, vBcl2), are present in numerous viral
families, including Herpesviridae, Poxviridae, Adenoviridae, and
Birnaviridae20. The sequence homology between vBcl2 and cBcl2
proteins varies considerably. However, the crystal structures of
some vBcl2s reveal a structural homology in key domains
between cBcl2 and vBcl2 despite no sequence homology, sug-
gesting functional commonalities5,21.
Here, we show that the Ct hydrophobic regions of herpesviral
and poxviral vBcl2s can operate as TMDs, effectively inserting the
protein into its target membrane. The vBcl2 TMDs facilitate
homo-oligomerization and hetero-oligomerization with pro- and
anti-apoptotic cBcl2 TMDs inside the membrane and in the
absence of apoptotic stimuli. These newly discovered interactions
participate in the regulation of cBcl2, thus modulating pro-
grammed cell death upon apoptotic stimuli. Furthermore,
our results suggest that inhibitors of these intramembrane PPIs
could be used therapeutically against life-threatening viral infec-
tions characterized by short- and long-term deregulation of
apoptosis.
Results
vBcl2 contain a functional Ct TMD. Like their cellular coun-
terparts, many vBcl2s present a hydrophobic region in their Ct
end. To identify whether these hydrophobic regions could act as
true TMDs, we selected six vBcl2 proteins from two distinct viral
families (3 herpesviruses and 3 poxviruses): BHRF1 (Human
gammaherpesvirus 4 – Epstein–Barr virus, HHV4)22, ORF16
(Human gammaherpesvirus 8 – Kaposi’s sarcoma–associated
herpesvirus, HHV8)23, ORF16 (Bovine gammaherpesvirus 4,
BoHV4)24, F1L (Vaccinia virus, VacV)25,26, M11L (Myxoma
virus, MyxV)26,27, and ORFV125 (Orf virus, OrfV)28. To avoid
confusion, here we use the viral acronym to refer to the vBcl2
protein.
First, we analyzed in silico the presence of TMDs in the
selected vBcl2. For this purpose, we used two TMD prediction
software packages, TMHMM v2.029,30 and the ΔG prediction
server31,32. Both algorithms identified a TMD in the Ct of HHV4,
HHV8, MyxV, and OrfV. Although the ΔG prediction server
identified a Ct TMD for BoHV4 and VacV, the TMHMM
software did not (Supplementary Fig. 1).
We then aimed to explore the membrane insertion capacity
of the predicted membrane-spanning segments using an
in vitro assay based on the E. coli leader peptidase (Lep), an
assay that allows for accurate and quantitative description of
the membrane insertion capability of short sequences. The Lep
sequence we employed contains an extended Nt luminal
section, followed by two TMDs (H1 and H2) connected by a
cytoplasmic loop, and a large luminal Ct domain. Two
glycosylation acceptor sites were inserted into the Lep (G1
and G2), one in each luminal domain (Nt and Ct ends)
(Fig. 1a). N-linked glycosylation occurs exclusively in the lumen
of the endoplasmic reticulum (ER) because of the location of
the oligosaccharyltransferase (OST) active site (a translocon-
associated enzyme responsible for the oligosaccharide trans-
fer33), thus serving as a topological marker. Glycosylation of an
acceptor site increases the apparent molecular mass of the
protein (~2.5 kDa), which facilitates its identification by gel
electrophoresis. When H1 and H2 are present, both G1 and G2
acceptor sites locate in the ER lumen and are subsequently
glycosylated. Likewise, if H2 is replaced by a sequence that the
translocon efficiently recognizes as a TMD, a double (G1 and
G2) glycosylation would be expected. In contrast, if H2 is
deleted or substituted by a protein segment that the translocon
does not recognized as a TMD, only G1 would remain in the
lumen, and single glycosylation will be observed (Fig. 1a).
Using this system, we studied the insertion of all six vBcl2
hydrophobic Ct domains (Fig. 1b). Additionally, the single TMD
of two mitochondrial membrane proteins, Tomm20 and
Tomm22 (T20 and T22), together with a construct in which
Lep was not altered were used as insertion controls. As a mono-
glycosylated control, we used the Ct region of the BH3-only
protein Noxa, a hydrophobic domain not recognized by the
translocon as a TMD11. The sequences for all non-viral proteins
referenced here can be found in Supplementary Fig. 2. Addition-
ally, we used a Lep mutant from which H2 was deleted as a
mono-glycosylated/non-insertion control (Supplementary Fig. 3).
To ensure that the increase in molecular weight was due to
glycosylation of the acceptor sites, OST samples were incubated
in the presence (+) or absence (−) of Endoglycosydase H
(EndoH), a glycan-removing enzyme. The results of the
glycosylation assay indicated that all vBcl2 hydrophobic regions,
including those derived from BoHV and VacV, were efficiently
inserted into ER-derived microsomal membranes (Fig. 1c).
Furthermore, the Lep assay revealed that all viral TMDs insert
into ER-derived membranes more efficiently than predicted by
the ΔG prediction server (Fig. 1b).
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Homo-oligomerization of the vBcl2 TMDs. cBcl2 TMD homo-
oligomerization has been reported in biological membranes17.
To assess whether vBcl2 TMDs exhibit this self-associating
property, we employed bimolecular fluorescent complementation
(BiFC) approach34 adapted for the study of intramembrane
interactions17,35. Briefly, TMDs were fused with two non-
fluorescent fragments of the venus fluorescent protein (VFP),
the VN (N terminus) and the VC (C terminus; Fig. 2a). Inter-
action of the TMDs facilitated the approximation of the VN and
VC ends and the reconstitution of the VFP protein structure and,
in consequence, the recovery of its fluorescent properties. As a
positive control and normalization tool, we included the TMD of
glycophorin A (GpA), a sialoglycoprotein found in human ery-
throcyte membranes that can form non-covalent dimers solely
through the association of its single hydrophobic TMD36–38. The
non-oligomerizing TMDs of the mitochondrial membrane pro-
teins T20 and T22 and H2 from Lep were used as negative
controls for membrane overcrowding (Fig. 2b).
The TMDs of HHV4, HHV8, VacV, MyxV, and OrfV
showed an interaction capability above the controls, including
T20 (used for the statistical analysis) and similar to that
observed with Bcl2 TMD (Fig. 2b). However, BoHV did not
show VFP fluorescence values significantly higher than the T20
control (Fig. 2b). Western blot analysis showed comparable
expression levels of all chimeras (Supplementary Fig. 4).
Because of the large variability, we decided to revise the results
obtained with BoHV TMDs. For this purpose, we used BlaTM,
a genetic tool designed to study TMD–TMD interactions in
bacterial membrane39.
Briefly, to measure interactions between TMDs, the designed
sequences were fused to either the Nt or the Ct end of a split β-
lactamase (βN and βC, respectively) and to the green fluorescent
protein (GFP) (Supplementary Fig. 5a). These chimeras also
included the pelB cleavable signal peptide, which directs the
protein to the inner bacterial membrane and determines its
topology, ensuring a periplasmic localization of the β-lactamase.
Once located in the inner membrane, an efficient TMD–TMD
interaction facilitates the reconstitution of the β-lactamase and
thus the growth of the bacteria in selective media (ampicillin). In
this assay, the LD50 of the antibiotic served as an indicator of the
interaction strength (Fig. 2c, d), and GFP fluorescence allowed for
rapid quantification of protein levels (Supplementary Fig. 5b). As
in the previous experiments, the TMD of GpA was used as a
positive control and normalization value across experimental
replicas, and the TMD of T20 was used as a negative control.
Additionally, the HHV8 TMD was included in the assay as an
extra control. In the BlaTM assay, both BoHV TMD and HHV8
TMD showed an interaction (ampicillin LD50) above the negative
control (Fig. 2c, d). Expression levels (measured using the GFP
fluorescence) were comparable for GpA, T20, HHV8, and BoHV
(Supplementary Fig. 5b).
By directly localizing to the mitochondria, Bcl2 controls
mitochondrial outer membrane (MOM) permeabilization and,
subsequently, apoptosis. In the mitochondria, Bcl2 can interact
through its TMD with other members of the Bcl2 family17.
Nonetheless, Bcl2 also localizes to other intracellular compart-
ments, including the ER and the Golgi apparatus40. To analyze
the location of the observed vBcl2 TMD homo-oligomers, we
expressed the appropriated BiFC partner combinations together
with an ER, mitochondrial, or plasma membrane marker
(Supplementary Fig. 6). Our results showed that all the assayed
TMD homo-oligomers occurred at the ER and at the
mitochondrial membranes. Of interest, the TMD oligomers of
VacV and MyxV could also be observed in the plasma
membrane. These results suggest a similar distribution for
vBcl2 and cBcl2.
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Fig. 1 Insertion of vBcl2 Ct hydrophobic sequences in eukaryotic
membranes. a A schematic representation of the leader peptidase (Lep)
model protein. G1 and G2 denote artificial glycosylation acceptor sites. The
sequence under investigation was introduced replacing the H2 domain of
Lep. Recognition of the tested sequence as a TMD by the translocon
machinery (highlighted in purple) results in the modification of the G1 and
G2 acceptor sites. The Lep chimera will be singly glycosylated if the
sequence being tested is not recognized as a TMD and thus not inserted
into ER-derived membranes (shown in orange). b The sequences (including
name and organism of origin) used in the assay are shown alongside their
predicted ΔG (ΔGpred) in kcal/mol, calculated using the ΔG prediction
server in its ΔG prediction mode. Residues shown in gray were not
considered by the ΔG prediction server. Additionally, the experimental ΔGs
in kcal/mol (ΔGexp), calculated based on the ratios between mono and
double glycosylated populations, are presented in the right column.
Experimental results are the average of at least four independent
experiments. Purple numbers indicate negative ΔGs (insertion of the tested
sequence), while orange numbers denote ΔG values above 0. c A
representative example (n= 4) of an in vitro protein translation in the
presence of ER-derived microsomes and in the presence (+) or absence
(−) of Endoglycosydase H (EndoH), a glycan-removing enzyme. The
absence of glycosylation of G1 and G2 acceptor sites is indicated by two
white dots, single glycosylation by one white and one black dot, and double
glycosylation by two black dots.
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cBcl2 and vBcl2 TMDs hetero-oligomerize in eukaryotic
membranes. Next, we decided to investigate the potential
TMD–TMD interactions between vBcl2s and cBcl2s. For this
purpose, we used the previously described BiFC approach. For
any given interaction (i.e., X/Y), two possible combinations with
the VFP fragments exist (VN-X/VC-Y and VN-Y/VC-X), so we
investigated both. Once again, the GpA TMD homodimer was
used as a positive control and a normalization value. As negative
controls, we used the interaction of each partner in the hetero-
oligomers with T20 TMD (i.e., for the X/Y interaction, X/T20 and
T20/Y). An interaction was considered only if the fluorescence
values were significantly higher than those of the two particular
negative controls. To reinforce our data, we included in the study
the interactions between the vBcl2 TMDs and T22 or H2 TMDs.
The mean relative fluorescence and standard deviation of all the
controls and the interactions between vBcl2 TMD and T22 TMD
and Lep H2 can be found in Supplementary Fig. 7. The assay was
carried out in human-derived cells despite the natural host of the
virus; however, the amino acid composition of the cBcl2s TMDs
are well conserved across the corresponding species (Supple-
mentary Fig. 8). First, we investigated the potential TMD–TMD
interactions between vBcl2s and the anti-apoptotic cBcl2s Bcl2
and BclXL (Fig. 3a, b). All of the viral TMDs could interact with
the TMD of Bcl2 in at least one of the assayed combinations. On
the other hand, although the majority of vBcl2 TMDs also
interacted with BclXL TMDs, BoHV and MyxV TMDs did not
(regardless of the partner combination used in the screening).
Next, because of the strength and consistency of the observed
signal, we decided to further characterize the Bcl2-HHV8
TMD–TMD interaction. First, we corroborated this intramem-
brane interaction by performing a competition assay. The Bcl2
and HHV8 TMD-driven homo-oligomers were challenged either
with the Bcl2 full-length protein (Bcl2-FL) or with a Bcl2 mutant
lacking the TMD (Bcl2 ΔTMD). The Bcl2 TMD homo-oligomer
was hindered when Bcl2-FL was co-expressed but not when the
Bcl2 ΔTMD construct was included in the assay (Fig. 4a).
Similarly, the addition of Bcl2-FL to the HHV8 TMD homo-
oligomer decreased the observed fluorescence compared with the
effect of the presence of Bcl2 ΔTMD. This result confirmed that
HHV8 and Bcl2 TMDs can interact and suggested that the
















































































Fig. 2 Homo-oligomerization in biological membranes. a A schematic representation of the Bimolecular Fluorescent Complementation (BiFC) assay. The
position of the Nt and Ct ends and the TMDs included in the constructs are indicated. The residues included in each VFP fragment are indicated below the
protein representation. b Relative fluorescence units (RFU) of each tested homo-oligomer in the BiFC assay. The mean and standard deviation of at least
three independent experiments are represented (n values 6, 3, 37, 9, 9, 12, 9, 5, 3, 9, respectively). The individual value of each experiment is represented
by a solid dot. The VN-GpA/VC-GpA homodimer, used as a positive control and to normalize values across experiments, is represented by a dotted line.
The T20, T22, and Lep H2 TMDs were included as negative controls (white bars). Those homo-oligomer that produced fluorescence levels significantly
higher than the T20 TMD homo-oligomer (two-tailed homoscedastic t-test) are highlighted in green, and those that did not are shown in light gray.
c Representative examples of dose–response curves used to calculate LD50 values in the BlaTM assay. The TMD homodimer of GpA was used as a positive
control (black), while the T20 TMD was used as a negative control (white). d BlaTM calculated mean and standard deviation LD50 of at least three
independent experiments (n= 3). The individual value of each experiment is represented by a solid dot. The βN-GpA/βC-GpA homodimer was used as a
positive control (black bar). The level of significance (p-value, two-tailed homoscedastic t-test) when comparing T20 (white bar) vs HHV8 (pink bar) or
BoHV (yellow bar) homo-oligomers is shown above the bars.
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Fig. 3 Hetero-oligomerization in Eukaryotic membranes. a–f Relative fluorescence (RFU) for the hetero-oligomerization of vBcl2 and cBcl2 TMDs. The
mean and standard deviation of at least three independent experiments are shown. Solid dots represent the results of individual experiments (n ranges
between 3 and 10). The TMD included in the VFP chimeras (VN or VC) is indicated below each bar. The GpA TMD homodimer was used as a positive
control and as the normalization value (dotted line). The interactions of each partner in the hetero-oligomers with T20 TMD were used as negative
controls (i.e., X/T20 and T20/Y for the X/Y interaction). The blue (VN/T20 TMD) and red (VC/T20 TMD) lines within each bar indicate the fluorescence
of the controls. An interaction (highlighted in green) was considered only if the RFU obtained was significantly higher (two-tailed homoscedastic t-test, p-
value < 0.05) than those of both negative controls. g Correlation of the BiFC assay results in HCT 116 and HEK 293T cells. Green dots indicate interactions
in HEK 293T cells. A linear trend line and the corresponding coefficient of correlation are shown.
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An in silico analysis of the potential dimer interface (done with
Preddimer, a TM segment dimer prediction software program41)
suggested that conserved glycine residues between Bcl2 and
HHV8 TMDs (at positions 158 and 227, respectively) could be
located at the contact surface of a putative HHV8-Bcl2
TMD–TMD heterodimer (Fig. 4b–d, and Supplementary Fig. 9a).
This positioning would create the appropriate environment for
ridge–groove arrangements, as observed for other interacting
TMDs36,37,42. Single amino acid substitutions were designed to
analyze the role of these glycine residues. Precisely, a mutation of
b
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Fig. 4 Interaction between HHV8 and Bcl2 TMDs. a The BiFC-derived fluorescence (RFU) for the homo-oligomerization of Bcl2 (left) or HHV8 (right)
TMDs was measured in the presence of Bcl2 (FL) or Bcl2 ΔTMD (ΔTMD) in HEK 293T cells. The mean and standard deviation of at least six independent
experiments are shown (n≥ 6). Solid dots represent the results of individual experiments. The GpA TMD homodimer was used as a positive control and as
the normalization value (dotted line). A significant (two-tailed homoscedastic t-test) decrease in the fluorescence is highlighted in gray, p-values are
indicated. b Sequence alignment of Bcl2 and HHV8 TMDs. The alignment was done with Clustal Omega (EMBL-EBI). c Predicted (PredDIMER) contact
area between Bcl2 and HHV8 TMDs. The position (length and angle) of each residue in a putative α-helix are indicated. A dotted line encircles the contact
area in each TMD. The hydrophobicity of the residues is shown with a color scale. As expected, there are many hydrophobic residues in both TMDs.
However, the contact area between both α-helices is mostly hydrophilic. d Model of a putative dimer between Bcl2 TMD and HHV8 TMD, obtained with
PredDIMER. The residues involved in the interaction are indicated, conserved glycine residues in Bcl2 and HHV8 are highlighted in bold. e Bcl2 and HHV8
TMD hetero-oligomerization measured by BiFC in HEK 293T cells. Fluorescence from the VN GpA/VC-GpA homodimer was used to normalize the signal
(dotted line). The mean and standard deviation of at least three independent experiments are shown (n≥ 3). Solid dots represent the results of individual
experiments. The blue (VN T20 TMD) and red (VC T20 TMD) lines indicate the fluorescence of the controls used for the statistical analysis (two-tailed
homoscedastic t-test), green bars denote RFU values above the controls, p-values are indicated.
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glycine 158 to leucine in HHV8 TMD (G158L) reduced the
observed interaction between Bcl2 and HHV8 TMDs in the BiFC
assay (Fig. 4e). Moreover, mutation of glycine residues in both
helices (G158L in HHV8 and G227L in Bcl2) further decreased
the fluorescence signal to levels significantly below those obtained
with the wild-type forms of the TMDs. Of note, the introduction
of G158L in HHV8 or G227L in Bcl2 did not alter insertion into
biological membranes (Supplementary Fig. 3). These results
indicate that the TMDs of Bcl2 and HHV8 can interact efficiently
and specifically at the mitochondrial and ER membranes through
arrangements in which the glycine residues have a crucial role.
We next analyzed the interactions between vBcl2 TMDs and
the TMDs of the cellular pro-apoptotic Bax and Bak proteins
(Fig. 3c, d). All three poxviral TMDs (VacV, MyxV, and OrfV)
could interact with Bax and Bak TMDs in the absence of
apoptotic stimuli and independent of any cytosolic (soluble)
domain interactions. On the other hand, herpesviral HHV4,
HHV8, and BoHV TMDs showed no interaction with either Bax
or Bak TMDs. MyxV protein interacts with Bak and Bax43,44
inhibiting the conformational activation of Bax43. Based on this
information, we decided to investigate the role of MyxV TMD
and its interaction with Bax TMD in the viral protein function.
For this purpose, we first decided to confirm the host–pathogen
intramembrane interaction using the previously described BlaTM
assay. The MyxV and Bax TMDs were inserted into the βN and
βC chimeras, respectively, and assayed together or in combina-
tion with the complementary chimeras carrying the TMD of T20
(Fig. 5a, b). The results of the BlaTM assay confirmed the
interaction between MyxV and Bax TMDs, which showed LD50
values that were significantly higher than the βN-T20/βC-T20,
βN-MyxV/βC-T20, and βN-T20/βC-Bax combinations.
Using the Preddimer algorithm, we analyzed the Bax
TMD–MyxV TMD interaction (Fig. 5c, d and Supplementary
Fig. 9b). Once again, the model showed an interaction in which a
ridge–groove arrangement was created by an adequate disposition
of large and small residues. Of interest, a large proportion of
aromatic residues was found at the interface of these two TMDs.
Amino acid substitutions were again designed to analyze the role
of the small residues. Mutation of glycine 158 to isoleucine in
MyxV TMD (G158I) or double mutation of glycine 179 and
alanine 183 to isoleucine in Bax TMD (G179I A183I) reduced the
interaction of Bax and MyxV TMDs in the BlaTM assay (Fig. 5e).
Moreover, the introduction of mutations in both helices (G158I
in MyxV and G179I A183I in Bax) further decreased antibiotic
resistance. Of note, mutations G158I in MyxV and G179I A183I
in Bax TMD did not alter membrane insertion (Supplementary
Fig. 3).
In eukaryotic cells, ectopic expression of Bax TMD induces
some caspase 3/7 activation and subsequently cell death, which
expression of the anti-apoptotic Bcl2 TMD can counteract,
thanks to the interaction among Bcl2 and Bax TMDs17. We
wondered whether the interaction between MyxV and Bax TMDs
also could preclude Bax TMD caspase activation. To test this
hypothesis, we co-expressed H2, Bcl2, or MyxV TMD with Bax
TMD and measured the resulting cell viability (Fig. 5f). In
agreement with the hetero-oligomerization results, Bcl2 and
MyxV TMDs, but not control H2 TMD, interfered with the Bax
TMD-induced apoptosis.
Next, to extend the BiFC-based screening of the intramem-
brane host–pathogen interactions between vBcl2s and cBcl2s, we
studied the interactions with the BH3-only apoptotic modulators
Bik and Bmf (Fig. 3e, f). The TMDs of HHV4, HHV8, VacV, and
OrfV could interact with the Bik TMD. However, according to
our results, viral interactions with Bmf were much sparser, and
only the HHV8 TMD could interact with Bmf TMD. All
intramembrane PPIs found between cellular and viral proteins are
summarized in Supplementary Fig. 10. For a more comprehensive
visualization, we also have included a network representation
(Supplementary Fig. 11). Additionally, the result of the BiFC-
based HEK 293T screening was confirmed in HCT 116 cells.
Despite some differences, a strong correlation between the BiFC
assay in both cell types can be observed (R2= 0.8) (Fig. 3g and
Supplementary Fig. 12).
While studying interaction with the BiFC assay (i.e., X/Y), we
observed some differences in the results obtained with each of the
two possible combinations (VN-X/VC-Y and VN-Y/VC-X).
Due to the nature of the BiFC assay, it is possible, as has
occurred in the case of the BlaTM assay, that the reporter signal
resulting from a TMD–TMD interaction depends not only on the
sequence of the interacting TMDs, and thus its inherent affinity,
but also on the orientation of the interacting surfaces of the
TMDs in relation to the accompanying signaling domains39. To
test our hypothesis we chose the first of the interactions where
significant differences between the two possible BiFC combina-
tions were found, i.e., the interaction between Bcl2 and BoHV
TMDs (Fig. 3a). Our screening revealed VN-BoHV/VC-Bcl2 as a
TMD–TMD interaction but not VN-Bcl2/VC-BoHV. To change
the orientation of the TMD with respect to the reporter domain
we inserted one (+1), two (+2), or three (+3) native residues at
the Nt end of BoHV TMD39. The observed fluorescence for the
interaction of the new BoHV TMD variants in combination with
the Bcl2 TMD were higher (and significantly above their controls)
than the interaction with the original design of the VN-BoHV
chimera (Supplementary Fig. 13). Although this result confirms
our hypothesis, due to a large number of interactions studied and
despite a large number of replicas, we cannot rule out the
presence of some false positive or negative results.
Collectively, these results point to an intricate network of
interactions between the TMDs of viral and cellular origin. A
comprehensive analysis of the data using a principal component
analysis (PCA) revealed that HHV4 and HHV8 TMDs from
herpesviral proteins behave similarly, as would have been
expected given their taxonomic proximity (Fig. 6a, b). Likewise,
the TMDs of a poxviral origin, particularly VacV and OrfV
TMDs, were tightly grouped in the PCA. However, the observed
similarities could not have been inferred by the analysis of the
TMDs sequences (Fig. 6c), which suggests a structural pattern
underlying the sequence that governs the TMD interactions.
Viral–host TMD–TMD interactions are necessary to modulate
apoptosis. To identify whether these newly found viral–host
TMD–TMD interactions are necessary to control cellular apop-
tosis, we transfected HeLa cells with Bcl2, HHV8, or MyxV either
with or without the TMD (FL and ΔTMD, respectively). Addi-
tionally, we included chimeras in which the TMD of each of the
previously mentioned proteins was replaced by the TMD of T20
(Bcl2-T20, HHV8-T20, and MyxV-T20, respectively), which our
previous results indicated cannot interact with any cBcl2 TMD.
Once transfected, cells were treated with doxorubicin to induce
apoptosis45.
As expected, the FL proteins could prevent apoptosis (Fig. 7a,
and Supplementary Fig. 14). However, once the TMD was
removed, none of the proteins could promote survival or stop
apoptosis. Similarly, the chimeras carrying the TMD of T20 could
not control the doxorubicin-induced apoptosis, suggesting that
the function of the viral TMDs extends beyond anchoring the
protein to the membrane and that TMD–TMD hetero-
oligomerizations are crucial for modulating viral-induced cell
death (Fig. 7a, b). Western blot analysis confirmed that
differences in expression levels were not the source of the
observed results (Fig. 7c).
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Fig. 5 Interaction between MyxV and Bax TMDs. a Representative example of dose–response curves used to calculate LD50 values in the BlaTM assay.
The TMD homodimer of GpA was used as a positive control (black), while the T20 TMD was used as a negative control (white). b Summary of the results
for the BlaTM assay. The indicated βN and βC chimeras were expressed in E. coli and the resulting ampicillin LD50 measured. LD50 mean and standard
deviation of at least three independent experiments (n≥ 3) are shown. Two-tailed homoscedastic t-test p-values are indicated. Solid dots represent the
results of individual experiments. c Predicted (PredDIMER) contact area between MyxV and Bax TMDs. The position (length and angle) of each residue in
a putative α-helix is indicated. A dotted line encircles the contact area in each TMD. The hydrophobicity of the residues is shown with a color scale.
d Model of a putative dimer between MyxV TMD and Bax TMD, obtained with PredDIMER. The residues involved in the interaction are indicated. Glycine
and alanine residues are highlighted in bold while aromatic residues are shown in red. e BlaTM analysis for the interaction between MyxV and Bax TMDs
carrying substitutions of Gly 158 (MyxV) and/or Gly 179 and Ala 183 (Bax) by Ile. LD50 mean and standard deviation of at least three independent
experiments are shown (n≥ 3), solid dots represent the results of individual experiments. f Bax TMD-induced cell death. Cells were transfected with Bax
TMD and H2, Bcl2 or MyxV TMD or mock-transfected; 24 hpt cell viability was measured by Trypan blue staining. Survival percentage mean and standard
deviation of five independent experiments (n= 5) are shown. Two-tailed homoscedastic t-test p-values are indicated. Solid dots represent the results of
individual experiments.
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Despite T20 being a mitochondrial-localized protein, the
substitution of the natural TMD on Bcl2, HHV8, or MyxV by
the T20 TMD could affect the localization of these proteins and
impede their anti-apoptotic role. To investigate this possibility,
we compared the localization of all three protein variants (FL,
ΔTMD, and T20) by fluorescent confocal microscopy. The
confocal analysis revealed that substitution of the natural TMD
with the T20 TMD did not alter the localization of the protein
(Supplementary Fig. 15). Furthermore, colocalization with a
mitochondrial marker was observed with the Bcl2, HHV8, and
MyxV-FL and all T20 variants. In contrast, the elimination of the
Ct TMD generated soluble proteins in all three cases. These
results suggest that the TMD, present in HHV8 and MyxV, not
only facilitated proper localization of the proteins but is also
necessary to establish interactions with host TMDs, which are
essential for the viral control of apoptosis.
Next, we transfected HeLa cells with Bcl2 and MyxV (FL and
T20 variants for both proteins) and induced apoptosis with Bax-
FL (Fig. 7d). Both Bcl2 and MyxV-FL proteins could rescue Bax-
induced apoptosis. However, the substitution of the TMD in
either Bcl2 or MyxV by the Ct membrane anchoring segment of
T20 eliminated their anti-apoptotic properties. Collectively, these
results not only suggest a potential role for the Bax–MyxV
TMD–TMD interaction during the viral infection but also
reinforce our screening results.
It has been proposed that MyxV helices 2, 3, 4, and 5 form a
binding groove for Bak and Bax46. Mutations in key positions of
this groove alter MyxV binding to the aforementioned pro-
apoptotic cellular proteins and subsequently disrupt its anti-
apoptotic action. To compare the influence of in-groove vs TMD
interactions, HeLa cells were transfected with MyxV-FL, T20, or
MyxV bearing substitutions in alanines 71 or 82 to phenylala-
nines (A71F and A82F respectively)46. To induce apoptosis, cells
were co-transfected with Bax-FL. Our results confirmed that
mutations in the binding groove of MyxV, primarily A82F, alter
MyxV pro-survival function (Supplementary Fig. 16a). However,
the substitution of MyxV TMD by T20 TMD produced a stronger
effect on the ability of the protein to rescue Bax-induced
apoptosis. Western blot analysis confirmed comparable expres-
sion levels for all of the FL, T20 A71F, and A82F variants
(Supplementary Fig. 16b).
vBcl2 and cBcl2 TMDs interactions control viral-induced
apoptosis. Finally, we aimed to explore whether vBcl2 TMD
interactions are necessary to control the apoptosis induced by a
viral infection. For this purpose, we infected HeLa cells with
VacV-PKR, a VacV recombinant strain expressing the double-
stranded RNA-dependent protein kinase (PKR) and capable of
inducing apoptosis47 and transfected with plasmids carrying Bcl2,
Bcl2-ΔTMD, Bcl2-T20, HHV8, HHV8-T20, MyxV, or MyxV-
T20 (under the control of an IPTG inducible promoter) or mock-
transfected with an empty plasmid. At 24 h.p.i., levels of caspases
3 and 7 activity and cell death were measured as a readout for
apoptosis (Fig. 8a, b). Bcl2-FL protein could partially block the
PKR-induced apoptosis48. However, Bcl2-ΔTMD or Bcl2-T20 did
not rescue cell death. Similarly, HHV8-FL and MyxV-FL sig-
nificantly reduced caspase 3/7 levels and decreased cell death. On
the other hand, HHV8-T20 or MyxV-T20, which includes a
TMD incapable of establishing intramembrane interactions, did
not reduce caspase 3/7 levels and were unable to control cell
death. To confirm these results, we infected HeLa cells with a
Modified Vaccinia Ankara virus strain lacking F1L protein
(MVA-ΔF1L) and capable of inducing apoptosis49 and trans-
fected with Bcl2-FL, Bcl2-ΔTMD, Bcl2-T20, HHV8-FL, HHV8-
T20, MyxV-FL, MyxV-T20, VacV-FL, pr VacV-T20 (under the
control of IPTG) or mock-transfected with an empty plasmid
(Fig. 8c, d). Additionally, the use of MVA-ΔF1L allowed us to
explore the role of TMD interactions in VacV vBcl2 (F1L). As in
the previous experiment (VacV-PKR, panels a and b), only pro-
teins bearing a TMD capable of establishing interactions (FL
variants) were able to control cellular apoptosis. In both experi-
ments, the western blot analysis confirmed comparable expres-
sion levels for all the FL, ΔTM, and T20 constructs (Fig. 8e). In


















































Fig. 6 TMD interaction and sequence profile. a, b Principal component analysis (PCA) of vBcl2 TMDs interaction profile with host TMDs. The colored
areas highlight the viral families, with poxviruses in light blue and herpesviruses in light yellow. The analysis was performed using only the BiFC assay
results. c vBcl2 TMDs Multiple Sequence Alignment. Results obtained with Clustal Omega (EMBL-EBI) using the default parameters.
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and host TMDs in the outer mitochondrial membrane are
required for the control of apoptosis in a viral infection scenario.
Discussion
To prevent the premature death of host cells, many viruses have
acquired the ability to modulate apoptosis. As a result, the virus
can replicate longer and circumvent activation of the immune
system18,50. This infection-induced effect can be permanent,
provoking the cell to persistently escape programmed cell death
despite paracrine or autocrine stimulus51. Indeed, 8–16% of new
cancer cases are attributable to carcinogenic infections52,53. Pre-
venting acute infection episodes as well as the long-lasting effects
associated with apoptosis evasion (including cancer) requires a
detailed understanding of how viruses control programmed cell
death. Viruses employ multiple strategies to block apoptosis. One
of the most notable, at least in DNA viruses, is the expression of
cellular pro-survival Bcl2 analogs20. Remarkably, many structural
elements of cBcl2, including a Ct hydrophobic region, are pre-
served in their viral replicas. Here, we explored the role of the
vBcl2 Ct domain in protein function. More specifically, we
focused on its function as a membrane anchor, its contribution to
host–host and viral–host PPIs, and its importance in the control
of cellular apoptosis.
In this report, we demonstrated that the cellular machinery
recognizes Ct regions of the tested vBcl2s as truly being TMDs
and therefore inserts them into the membrane despite a low
hydrophobicity score for some of these regions (BoHV, MyxV).
Furthermore, a positive (suggesting no insertion) ΔGpred value for
the insertion into lipid bilayers was predicted for VacV Ct region.
Nonetheless, this predicted penalty did not preclude VacV Ct
insertion. In fact, all the ΔGexp values obtained in vitro were
below −1 kcal/mol, suggesting a strong membrane insertion
capacity.
Permeabilization of the MOM, considered in most cases the
point of irreversible commitment to apoptosis, is controlled by
interactions among pro- and anti-apoptotic Bcl2 members54.
Most members of the Bcl2 family, including BH3-only proteins,
bear a Ct TMD necessary for both their subcellular localization
and apoptotic activity. Additionally, Bax and Bcl2 TMDs have
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Fig. 7 The role of vBcl2 TMD in apoptotic control. a Role of vBcl2 TMD in control of doxorubicin-induced apoptosis. Cells were transfected with Bcl2,
HHV8, and MyxV with (FL) or without the TMD (ΔTMD), or with the TMD substituted by the TMD of T20 (T20). Cells were then treated with
doxorubicin and the percentage of surviving cells was calculated by Trypan blue staining. The survival percentage mean and standard deviation of at least
three independent experiments are shown (n≥ 3). Solid dots represent the results of individual experiments. Transfection with an empty plasmid (Empty)
was used as a negative control. Statistical differences are based on a two-tailed homoscedastic t-test (p-values are indicated above the corresponding bar,
ns non-significant). b Alternatively, the percentage of cells in healthy, early apoptotic, late apoptotic, or necrotic states was measured by flow cytometry
using propidium iodide staining and phosphatidyl serine labeling (FITC-Annexin V). The average percentage of cells in each of the aforementioned
populations is shown. c Western blot analysis of protein levels. Histone 3 (H3) was used as a loading control (n= 3). d Role of MyxV TMD in Bax-induced
apoptosis. Cells were transfected with Bcl2 and MyxV (FL) or with the TMD substituted by the TMD of T20 (T20) and co-transfected with (+) or without
(−) Bax-FL as an apoptosis stimulus. Survival percentage mean and standard deviation of three independent experiments are shown (n= 3). Solid dots
represent the results of individual experiments. Statistical differences are based on a two-tailed homoscedastic t-test (p-values are shown above the
corresponding bars).
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information, coupled with the newly discovered membrane-
spanning capacity of the vBcl2 Ct hydrophobic region, led us to
explore the homo-oligomerization potential of the newly identi-
fied vBcl2 TMDs. Our findings using two different com-
plementation assays, i.e., BiFC and BlaTM, suggest that all vBcl2
TMDs can form intramembrane homo-oligomers. Sequence-
specific TMD oligomerization is influenced by lipid bilayer
properties and thus its composition55–57. Our results indicate that
the BiFC-observed homo-oligomers can form in vivo at the ER
and mitochondrial membranes. It is particularly interesting to
find these anti-apoptotic homo-oligomers at the mitochondrial
































































































































Fig. 8 The role of viral TMDs on viral-induced apoptosis control. a, b HeLa cells were co-infected with VacV-PKR and VT7LacOI (MOI 2.5 for each virus)
and transfected with 50 ng of the plasmids Bcl2-FL, Bcl2-ΔTMD, Bcl2-T20, HHV8, HHV8-T20, MyxV, and MyxV-T20 or with an empty plasmid. IPTG was
then added to induce protein expression. At 24 h.p.i, apoptosis was measured from duplicate samples using the Caspase-Glo 3/7 assay kit (a) or by
measuring cell viability with Trypan blue staining (b). The mean and standard deviation of four technical replicates from two independent experiments are
shown. Solid dots represent the results of individual replicates. Cells transfected with an empty plasmid were used as a control. Statistical differences are
based on a two-tailed homoscedastic t-test, p-values are indicated above the corresponding bar. c, d HeLa cells were co-infected with VT7LacOI and MVA-
C-ΔF1L deletion mutant (MOI 2.5 of each virus) and transfected with 50 ng of the plasmids Bcl2-FL, Bcl2-ΔTMD, Bcl2-T20, HHV8, HHV8-T20, MyxV,
MyxV-T20, VacV, and VacV-T20 or with an empty plasmid. IPTG was then added to induce protein expression. At 24 h.p.i, apoptosis was measured from
samples using the Caspase-Glo 3/7 assay kit (c) or by measuring cell viability by Trypan blue staining (d). The mean and standard deviation of four
technical replicates from two independent experiments are shown. Cells transfected with an empty plasmid were used as control. Statistical differences are
based on a two-tailed homoscedastic t-test, p-values are indicated above the corresponding bar. e Western blot analysis of Bcl2, HHV8, MyxV, and VacV
with (FL) or without the TMD (ΔTMD) or with the TMD of T20. All viral proteins included a c-Myc tag. Beta-actin was used as a loading control (n= 3).
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other pro-apoptotic Bcl2 proteins58. These results not only
indicate a similar distribution for vBcl2 and cBcl2 but also raise
the possibility of a potential dynamic intracellular localization
for vBcl2.
Despite some drawbacks, such as an elevated number of
replicates needed or difficulty automating the process, we believe
that the BiFC-based approach is particularly well suited for our
study. The BiFC assay not only allowed us to conduct our
experiments in eukaryotic cells but also replicated the native
membrane topology of the vBcl2 proteins. Proteins with no signal
peptide and a single TMD in their Ct end (known as tail-
anchored proteins), such as the Bcl2 family, are a minority within
the cellular membrane proteome (3–5%)59. By locating the TMD
at the Ct end of our chimeras, we replicated its natural location/
orientation and any potential for TMD–TMD interaction. Fur-
thermore, the BiFC assay facilitated the study of hetero-
oligomerizations and the identification of the subcellular com-
partment where the interactions occur.
Using BiFC, we also analyzed the potential TMD–TMD
interactions between vBcl2 and cBcl2. Our results revealed a
previously overlooked host–pathogen intramembrane interaction
network. It should be noted that intramembrane oligomers can be
fragile because of the small interaction surface between
monomers44,60–62 This history indicates that at least in some
cases, the contact between the cellular and viral proteins occurs at
the same time through soluble and membrane-spanning regions.
Of interest, all the viral TMDs we tested here, except that of
BoHV, could interact with multiple cellular TMDs. The parti-
cularities of these connection circuits varied from virus to virus,
potentially reflecting distinctive mechanisms of action. Indeed, a
comprehensive PCA of the TMD–TMD interaction data revealed
a similar interaction pattern for herpesviral HHV4 and HHV8
members on one hand, and poxviral VacV and OrfV members on
the other. These similarities among closely related viruses might
also suggest that the interaction network of each TMD is
important for the survival of the virus so that it has been con-
served throughout its evolution. Otherwise, the interaction pat-
tern of each TMD would have been lost through the fast mutation
rate and high evolutionary pressure scenario associated with the
virus. Sequence similarity would have been expected to accom-
pany similarities in the vBcl2 TMD interaction pattern. However,
as the sequence alignment exposed, in the TMDs of the analyzed
proteins, no sequence homology pattern could explain the
observed results. This finding implies the presence of a structural
pattern underlying the sequence that could govern the
TMD–TMD interactions and that has been conserved throughout
viral evolution. Of note, the similarities in the interaction network
between closely related viruses also suggest that the observed
interactions are not the result of random contacts among TMDs
resulting from non-specific affinities or overcrowding.
Our assays allowed us to analyze each potential interaction
independently. However, for each vBcl2 protein in vivo, all the
TMD–TMD interactions with cBcl2s could occur at once. It
remains to be confirmed whether there is a preferred (hier-
archical) interaction that is responsible for the anti-apoptotic
effect or there are several TMD–TMD interactions that occur
side-by-side, all of them contributing to the cell death blockage.
Currently, data exist to support either possibility. On the one
hand, vBcl2s can interact with multiple cBcl2s. For example, as
recently demonstrated, HHV4 drives chemoresistance and lym-
phomagenesis by inhibiting multiple cellular pro-apoptotic pro-
teins61. On the other hand, a hierarchic interaction profile for the
TMDs of cBcl2 has also been observed63. These two possibilities
are not exclusive and most likely occur simultaneously in
the cells.
According to our results, vBcl2 TMD are capable of forming
homo- and hetero-oligomers. These two types of interactions
might not be exclusive but collaborative/synergistic. The techni-
ques we used for the study of hetero-oligomers (BiFC and BlaTM)
do not impede the formation of homo-oligomers alongside them.
In these assays, the formation of a heterodimer is required to
obtain fluorescence (BiFC) or antibiotic resistance (BlaTM).
Nonetheless, it is possible (even probable) that homo-oligomers
are formed prior to the interaction between a viral and a cellular
TMD. Indeed, VacV has been shown to adopt a dimeric fold
through its soluble region which enables hetero-oligomeric
binding to pro-apoptotic members of the Bcl2 family64. In this
case, it is likely that the TMD first participates in the formation of
the homodimer and then in the interaction with cBcl2.
Next, we focused on the TMD–TMD interaction between the
strong partners Bcl2-HHV8 and Bax-MyxV. Bcl2 and HHV8
TMDs were detected in mitochondrial membranes where Bcl2 is
thought to interact with pro-apoptotic members of the Bcl2
family to control apoptosis. Whether HHV8 requires its inter-
action with Bcl2 to exert its anti-apoptotic function remains to be
seen. Our data also revealed that the presence of the soluble
domains of Bcl2 did not affect TMD–TMD interaction between
Bcl2 and HHV8 (Fig. 4a), reinforcing the idea that intramem-
brane interactions could occur side-by-side with contacts through
soluble domains. With respect to the MyxV-Bax intramembrane
interaction, we not only confirmed the interaction seen with the
BiFC assay but also demonstrated that MyxV TMD can inhibit
Bax TMD-induced apoptosis (Fig. 5). Furthermore, MyxV-FL but
not MyxV-T20 could rescue Bax-FL-induced apoptosis. These
results might imply that MyxV can exert its anti-apoptotic action
through direct interactions with pro-apoptotic Bax (in agreement
with the previous results43) and that its TMD is a key domain
that plays an active role in the control of cell death. Nonetheless,
other scenarios in which a third protein is involved cannot be
ruled out. Of interest, the in silico analysis of both the putative
HHV8-Bcl2 and the MyxV-Bax intramembrane dimers revealed
ridge–groove arrangements between small and large residues in
opposing TMDs. This type of interaction has been observed
previously in other TMD dimers, particularly in the case of the
GpA homodimer.
Finally, our results, using both drug and viral apoptotic stimuli,
indicated that the TMD in the vBcl2s is necessary for the control
of apoptosis. Furthermore, when HHV8, MyxV, or VacV lose
their ability to interact with cellular proteins through the TMD,
they become incapable of regulating apoptosis, as demonstrated
when the TMD in the vBcl2 was deleted or substituted by the
TMD of T20 (Figs. 7 and 8). These results open the way to the
design of new antivirals that could interfere with these hosts–viral
TMD–TMD interactions. Of interest, MyxV-FL behaved as a
strong apoptosis inhibitor regardless of the stimuli. In contrast,
HHV8-FL worked better as an apoptosis inhibitor when PKR
(under a VacV promoter) was used as the stimulus. This diver-
gence between MyxV and HHV8 suggests a difference in their
mechanism of action, which could also be inferred by analyzing
the interaction profile of their TMDs (Fig. 6 and Supplementary
Fig. 10).
In conclusion, we have identified the Ct hydrophobic region
of the vBcl2 as a true TMD that can interact with cBcl2 TMDs.
We also have demonstrated that these intramembrane inter-
actions are crucial for the viral control of cell fate. This
work advances our understanding of how viruses control cel-
lular apoptosis for their advantage and how apoptosis is
regulated in the cell. Furthermore, the interactions described
here expand knowledge about how viruses interact with
their host.
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Methods
Cell cultures, plasmids, and reagents. Human embryonic kidney 293T cells
(HEK 293T), human colorectal carcinoma-derived cells (HCT 116), and human
epithelial cervical cancer cells (HeLa) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS)
(Gibco), and penicillin–streptomycin (P/S) (100 U/mL) (Gibco). All cells were
grown at 37 °C, 5% CO2.
The TMD sequences were synthesized by Invitrogen (GeneArt gene synthesis),
PCR amplified, and subcloned into the appropriated vector either using a standard
digestion-ligation protocol or using the InFusion cloning system following the
manufacturer’s protocol (Takara). Mutations into the TMD were introduced by
site-directed mutagenesis using the Quick Change II kit following the
manufacturer’s instructions (Agilent Technologies). A full list of all the primers can
be found in Supplementary Table 1. All DNA manipulations were confirmed by the
sequencing of plasmid DNAs (Macrogen). Transfection of DNA into eukaryotic
cells was performed in Opti-MEM reduced serum medium (Gibco) with
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s specifications.
The recommendations of the International Committee on Taxonomy of Viruses
(http://www.ictvonline.org/index.asp) were used as guidelines for the viral
nomenclature.
In vitro transcription and translation. The Lep-derived constructs were assayed
using the TNT T7 Quick Coupled System (#L1170, Promega). Each reaction
containing 1 µL of PCR product, 0.5 µL of EasyTag™ EXPRESS 35S Protein
Labeling Mix (Perkin Elmer) (5.5 µCi), and 0.3 µL of microsomes (tRNA Probes)
was incubated at 30 °C for 90 min. Samples were analyzed by SDS-PAGE. The
bands were quantified using a Fuji FLA-3000 phosphoimager and the Image
Reader 8.1 software. Free energy was calculated using: ΔGapp=−RT lnKapp, where
Kapp= f2g/f1g being f1g and f2g the fraction of single glycosylated and double
glycosylated protein, respectively. Endoglycosidase H treatment (Roche) was car-
ried according to the specifications of the manufacturer.
Bimolecular fluorescent complementation (BiFC) assay. For the generation of
BiFC chimeric plasmids including the Nt or Ct of the Venus Fluorescent Protein
(VN, VC, respectively) Addgene #27097, #22011 (a gift from Chang-Deng H)65
plasmids were modified to clone the cellular and viral Bcl2 TMDs at the Ct of the
VFP. Chimeras (500 ng VN+ 500 ng VC) were transfected into 2 × 105 HEK
293T cells together with a plasmid expressing Renilla luciferase under the CMV
promoter (pRL-CMV) (50 ng) for signal normalization. Additionally, for the
competition assay, 500 ng of a plasmid encoding Bcl2 full-length or Bcl2 lacking
the TMD were transfected. Cells were incubated at 37 °C, 5% CO2 for 48 h, PBS
washed and collected for fluorescence and luciferase measurements (Victor X3
plate reader). For the Renilla luciferase readings, we used the Renilla Luciferase
Glow Assay Kit (Pierce, Thermofisher) according to the manufacturer’s protocol.
In each experiment, the fluorescence/luminescence ratio obtained with the GpA
homodimer was used as a 100% oligomerization value and the rest of the values
adjusted accordingly. All experiments were done at least in triplicates.
BlaTM assay. Competent E. coli BL21-DE3 cells were co-transformed with N-BLa
and C-BLa plasmids, version 1.139, containing a given TMD pair and grown
overnight at 37 °C on LB-agar plates containing 34 μg/mL of chloramphenicol
(Cm) and 35 μg/mL of kanamycin (Kan) for plasmid inheritance. After o/n
incubation at 37 °C, colonies were either picked for immediate use or the plates
were sealed with Parafilm (Pechiney Plastic Packaging) and stored at 4 °C for up to
one week. Overnight cultures were conducted by inoculating 5 mL of LB-medium
(Cm, Kan) with 10 colonies from one agar plate, followed by o/n incubation in an
orbital incubator at 37 °C, 200 rpm. An expression culture was started with a 1:10
dilution of the overnight culture in 4 mL expression medium: LB-medium (Cm,
Kan) containing 1.33 mM arabinose. After 4 h at 37 °C, the expression cultures
were diluted to an OD600= 0.1 in expression medium. To expose the bacteria to
different ampicillin concentrations, an LD50 culture was prepared by pipetting 100
μL of the diluted expression culture into each cavity of a 96-deep well plate
(96 square well, 2 mL, VWR) containing 400 μL of expression media (final OD600
= 0.02). Freshly prepared ampicillin stock (100 mg/mL in ethanol) was added,
resulting in ampicillin concentrations ranging from 0 to 350 μg/mL, depending on
the affinity of the TMD under investigation. As a rule, the maximum ampicillin
concentration to be used for a particular case should be about twice the mean LD50.
The plates were incubated in a moisturized container for 16 h at 37 °C and 250 rpm
on a shaker (shaking amplitude 10 mm, KS 260 Basic, IKA) containing tips in every
well to ensure a proper agitation. Cell density was measured via absorbance at 544
nm in a microplate reader (Victor X3, Perkin Elmer). To minimize clonal variation,
at least two transformations were done and at least two separate LD50 cultures were
inoculated from each batch of transformed bacteria using ten colonies for each
culture. Thus, at least 40 colonies entered each determination of LD50. To measure
and collect LD50 values from the dose–response curves, we used Prism 8 from
GraphPad.
To analyze the expression levels of the chimeras, competent E. coli BL21-DE3
cells were transformed with one N-BLa or C-BLa plasmid, version 1.1, containing a
given TMD and grown overnight at 37 °C on LB-agar plates containing 34 μg/mL
of Cm (for N-BLa) or 35 μg/mL of Kan (for C-BLa) for plasmid inheritance. After
o/n incubation at 37 °C, cultures were conducted by inoculating 5 mL of LB-
medium (Cm or Kan) with 10 colonies from one agar plate, followed by o/n
incubation in an orbital incubator at 37 °C, 200 rpm. An expression culture was
started with a 1:10 dilution from the overnight culture in 4 mL expression medium:
LB-medium (Cm or Kan) containing 1.33 mM arabinose. After 4 h at 37 °C, the
expression cultures were diluted to an OD600= 0.1 in 5 ml of expression medium
(final volume) and grown o/n, 37 °C, 200xg. The morning after, 100 μL from each
culture were transferred to a black 96-well plate to measure the fluorescence
(Victor X3, Perkin Elmer).
Cell-viability assays. To measure doxorubicin-induced apoptosis 1.5 × 106 HeLa
cells were plated in a 24 wells plate containing 0.5 ml of media in each well. After
overnight incubation, each well was transfected in triplicates with 500 ng of DNA.
After two days of expression, cells were treated with doxorubicin (stock 2 mM in
DMSO) achieving a final concentration of 15 µM. Approximately, 16 h post-
treatment cells (including those in the supernatant) were collected and their via-
bility was measured using Trypan blue and using an automated cell counter
(Invitrogen, Countess™ II). At least, 2 measurements per well were done. Addi-
tionally, the viability and apoptotic state of the cells was measured using the BD
Annexin V: FITC Apoptosis Detection Kit II according to the manufacturer spe-
cifications and a BD LSR-Fortessa (Beckton Dickinson). All flow cytometry
countings were done at the tissue culture and flow cytometry core facilities of the
SCSIE (University of Valencia) following the recommendations of the BD Annexin
V: FITC Apoptosis Detection Kit II. To measure Bax TMD-induced apoptosis HCT
116 cells were transfected with 250 ng of the plasmid encoding VN-Bax and 250 ng
of either VC-H2, VC-Bcl2 or VC-MyxV encoding plasmids or mock-transfected.
After 48 h, cells were trypsinized and viability was measured twice per well using
Trypan Blue and automated Countess™ II cell counter (Invitrogen). The percentage
of survival was calculated using the mock-transfected cells as the reference value.
To measure Bax-induced apoptosis, 3 × 106 HeLa cells were plated in a 24-well
plate (0.5 ml of media in each well). After overnight incubation, cells were
transfected (in triplicate) with 500 ng of either MyxV-FL, M11L-T20, Bcl2-FL,
Bcl2-T20, or empty pCAGGS (negative control). Additionally, cells were co-
transfected with 400 ng of Bax DNA. For the positive control, 500 ng of Bcl2-FL
and 400 ng of empty pCAGGS were transfected. After 24 hrs of expression, cells
were collected and their viability was measured using Trypan blue and an
automated cell counter (Invitrogen, Countess™ II). At least 2 measurements were
done per well.
Bio-informatic resources. Prediction of the TMD on full-length sequences was
done either with the ΔG prediction server v1.031,32 or the TMHMM server v2.029,30
using default parameters. Principal Component Analysis (PCA) was done with the
Gene Expression Similarity Investigation Suite (Genesis)66 (http://genome.tugraz.at)
using the default parameters. For the multiple sequence alignment, Clustal
Omega was launched from the EMBL-EBI site67. Contact surface predictions for
TM dimers were done with PREDDIMER67 (http://model.nmr.ru/preddimer/).
From all the options provided by the algorithm, only the lowest energy option was
considered.
Confocal microscopy. Confocal micrographs were done at the Microscopy Core
Facility of the SCSIE (University of Valencia) using an Olympus FV1000 confocal
microscope with a ×60 oil lens. ER (Sec61β), plasma membrane (the first twenty
residues of neuromodulin) and, mitochondria (Tomm20) mCherry fluorescent-
labeled markers were obtained from Addgene plasmid repository #4915568,
#5577969 and #55146 (a gift from Michael Davidson, Institute of Molecular Bio-
physics and Center for Materials Research and Technology, The Florida State
University) respectively. Cells (5 × 103 cells/well) were seeded on 10 mm cover-
slides treated with poly-Lys and placed in 24-well plates. The next day, cells were
transfected with the appropriate plasmids. After 24 h, the cells were fixed (4%
paraformaldehyde) and DAPI stained before image capture. A 1:1000 dilution in
TBS 0.005% Tween Rabbit anti c-Myc (Sigma PLA0001) antibody followed by an
anti-Rabbit Alexa 488 conjugated (Life Technologies A21206) (1:1000) was used to
label viral proteins. Pictures were taken in an Olympus FV1000 confocal micro-
scope. Laser intensity was individually adjusted in all samples. Pictures were not
used for quantification.
Viruses and infections. The VacV recombinants used in this study have been
previously described: VacV-PKR (previously named as VV-p68)48, which expresses
the dsRNA-dependent protein kinase upon induction of the isopropyl β-D-thio-
galactosidase (IPTG)-dependent inducible promoter, VT7LacOI that expresses the
T7 RNA polymerase in an IPTG-dependent manner, the parental MVA-C and the
deletion mutant MVA-C-ΔF1L lacking the viral F1L gene49. To express viral and
cBcl2 proteins alongside viral infection, the selected DNA sequences were cloned
into pVOTE.270 plasmid under the control of the IPTG-dependent inducible T7
promoter. Infections were performed on pre-confluent (<75%) cell monolayers.
Cultures were co-infected with VT7LacOI and either VV-PKR, MVA-C, or MVA-
C-ΔFIL diluted in DMEM to a multiplicity of infection (MOI) of 2.5 PFU/cell of
each virus. After the one-hour adsorption cells were transfected with 50 ng of the
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indicated plasmid. Transfections of infected cells were performed with Lipofecta-
mine 2000 reagent (Invitrogen), following the protocol recommended by the
supplier. Infected cells were incubated in the presence of IPTG (5 mM) at 37 °C
until 24 h.p.i.
Caspase 3/7 activity assay. Quantification of caspase activity was carried out by
using the Caspase-Glo 3/7 assay kit (Promega) following the protocol recom-
mended by the supplier. HeLa cell monolayers grown in 24-well plates were
infected and transfected, in duplicate, under the conditions indicated above. At 24
h.p.i. cells were harvested in medium and kept frozen until their analysis. 25 µL of
the cell lysates under study was added to 25 µL of Caspase-Glo 3/7 reagent in a 96-
well plate. Plates were gently shaken and then incubated in the dark at room
temperature for 60 min before recording the luciferase activity by using an
Appliskan luminometer (ThermoScientific).
Western blot analysis. Cell monolayers were lysed in Laemmli´s sample buffer
(62.5 mM Tris-HCl [pH 6.8], 2% sodium dodecyl sulfate [SDS], 0.01% bromo-
phenol blue, 10% glycerol and 5% β-mercaptoethanol). Protein samples were
subjected to 12% SDS-polyacrylamide gel electrophoresis (PAGE) and transferred
to nitrocellulose membranes (BioRad). Membranes were blocked for 30 min at
room temperature in Tris-buffered saline supplemented with 0.05% Tween 20
(TBS-T) containing 5% non-fat dry milk, and later incubated with primary anti-
bodies diluted in the same buffer at 4 °C overnight. Antibodies used in this study
were β-actin (Santa Cruz Biotechnology SC-47778), c-Myc (Sigma PLA0001 or
Roche 11667149001), Histone 3 (Sigma H0164), and Flag (Sigma B3111). Then,
membranes were washed with TBS-T and incubated with goat anti-mouse IgG-
peroxidase conjugate (Sigma DC02L) for 1 h at room temperature and washed
again. All antibodies were used at a 1:10,000 dilution in TBS-T with 5% non-fat dry
milk. Detection of immunoreactive proteins was carried out using the enhanced
chemiluminescence (ECL) reaction (SuperSignal ThermoScientific) and detected by
the ChemiDoc Touch Imaging System (BioRad).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request. Source data are provided with this paper.
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